151 related articles for article (PubMed ID: 20955461)
41. Global use of Haemophilus influenzae type b conjugate vaccine.
Ojo LR; O'Loughlin RE; Cohen AL; Loo JD; Edmond KM; Shetty SS; Bear AP; Privor-Dumm L; Griffiths UK; Hajjeh R
Vaccine; 2010 Oct; 28(43):7117-22. PubMed ID: 20691265
[TBL] [Abstract][Full Text] [Related]
42. The effectiveness of conjugate Haemophilus influenzae type B vaccine in The Gambia 14 years after introduction.
Howie SR; Oluwalana C; Secka O; Scott S; Ideh RC; Ebruke BE; Balloch A; Sambou S; Erskine J; Lowe Y; Corrah T; Adegbola RA
Clin Infect Dis; 2013 Dec; 57(11):1527-34. PubMed ID: 24046305
[TBL] [Abstract][Full Text] [Related]
43. Persistence of immunity following a booster dose of Haemophilus influenzae type B-Meningococcal serogroup C glycoconjugate vaccine: follow-up of a randomized controlled trial.
Khatami A; Snape MD; John T; Westcar S; Klinger C; Rollinson L; Boutriau D; Mesaros N; Wysocki J; Galaj A; Yu LM; Pollard AJ
Pediatr Infect Dis J; 2011 Mar; 30(3):197-202. PubMed ID: 20844459
[TBL] [Abstract][Full Text] [Related]
44. Haemophilus influenzae serotype b vaccine failure: what is the significance of antibody levels?
Spanjaard L; Rijkers GT
Clin Infect Dis; 2009 Aug; 49(3):381-2. PubMed ID: 19580417
[No Abstract] [Full Text] [Related]
45. Circulating innate and adaptive immunity against anti-Haemophilus influenzae type b.
Zarei AE; Linjawi MH; Redwan EM
Hum Antibodies; 2019; 27(3):201-212. PubMed ID: 30958343
[TBL] [Abstract][Full Text] [Related]
46. Anti-polyribosylribitol phosphate antibody in pediatric patients with Haemophilus influenzae type b invasive disease.
Ishiwada N; Honda Y; Tanaka J; Hishiki H; Kohno Y
J Infect Chemother; 2011 Jun; 17(3):397-400. PubMed ID: 21188446
[TBL] [Abstract][Full Text] [Related]
47. Challenges in immunisation against bacterial infection in children.
Trück J; Pollard AJ
Early Hum Dev; 2010 Nov; 86(11):695-701. PubMed ID: 20851537
[TBL] [Abstract][Full Text] [Related]
48. Serological protection induced by Haemophilus influenzae Type B conjugate vaccine in Mexican children: is a booster dose of the vaccine needed?
Rodriguez RS; Mascarenas C; Conde-Glez CJ; Inostroza J; Villanueva S; Velázquez ME; Sánchez-Alemán MA; Echániz G
Clin Vaccine Immunol; 2010 Oct; 17(10):1639-41. PubMed ID: 20719986
[TBL] [Abstract][Full Text] [Related]
49. Changes in the epidemiology of epiglottitis following introduction of Haemophilus influenzae type b (Hib) conjugate vaccines in England: a comparison of two data sources.
McVernon J; Slack MP; Ramsay ME
Epidemiol Infect; 2006 Jun; 134(3):570-2. PubMed ID: 16288684
[TBL] [Abstract][Full Text] [Related]
50. Comparison of Haemophilus influenzae Seroprevalence in Serum Samples Collected from 0- to 5-Year-Old Japanese Children in 1980, 1995, 2010, and 2012.
Arai S; Satoh H; Okuno H; Morino S; Oishi K; Tanaka-Taya K
Jpn J Infect Dis; 2020 Jan; 73(1):51-54. PubMed ID: 31474695
[TBL] [Abstract][Full Text] [Related]
51. Immunoglobulin deficiency in children with Hib vaccine failure.
Ladhani S; Oeser C; Sheldon J; Ramsay M; Booy R; Heath PT
Vaccine; 2011 Nov; 29(49):9137-40. PubMed ID: 21983357
[TBL] [Abstract][Full Text] [Related]
52. Immunization with Haemophilus influenzae (Hib) conjugate vaccine following discharge from hospital.
Olowokure B; Spencer NJ; Hawker JI; Blair I
Infection; 2003 Oct; 31(5):324-6. PubMed ID: 14556057
[TBL] [Abstract][Full Text] [Related]
53. Persistence of antibody responses to Haemophilus influenzae type b polysaccharide conjugate vaccine in children with vertically acquired human immunodeficiency virus infection.
Gibb D; Giacomelli A; Masters J; Spoulou V; Ruga E; Griffiths H; Kroll S; Giaquinto C; Goldblatt D
Pediatr Infect Dis J; 1996 Dec; 15(12):1097-101. PubMed ID: 8970219
[TBL] [Abstract][Full Text] [Related]
54. IgE anti-Haemophilus influenzae type b (Hib) antibodies detected in serum of Hib-vaccinated asthmatic and non-asthmatic pediatric patients.
Smith-Norowitz TA; Saadia TA; Banniettis N; Norowitz YM; Joks R; Hammerschlag MR; Durkin HG; Kohlhoff S
Minerva Pediatr; 2018 Apr; 70(2):111-116. PubMed ID: 27187042
[TBL] [Abstract][Full Text] [Related]
55. Licensure of a Haemophilus influenzae type b (Hib) vaccine (Hiberix) and updated recommendations for use of Hib vaccine.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2009 Sep; 58(36):1008-9. PubMed ID: 19763078
[TBL] [Abstract][Full Text] [Related]
56. T helper cells and efficacy of Haemophilus influenzae type b conjugate vaccination.
McVernon J; Mitchison NA; Moxon ER
Lancet Infect Dis; 2004 Jan; 4(1):40-3. PubMed ID: 14720567
[TBL] [Abstract][Full Text] [Related]
57. Risk of invasive Haemophilus influenzae type b (Hib) disease in adults with secondary immunodeficiency in the post-Hib vaccine era.
Nix EB; Hawdon N; Gravelle S; Biman B; Brigden M; Malik S; McCready W; Ferroni G; Ulanova M
Clin Vaccine Immunol; 2012 May; 19(5):766-71. PubMed ID: 22398246
[TBL] [Abstract][Full Text] [Related]
58. Response of human immunodeficiency virus-exposed and -infected infants to Haemophilus influenzae type b conjugate vaccine.
Rutstein RM; Rudy BJ; Cnaan A
Arch Pediatr Adolesc Med; 1996 Aug; 150(8):838-41. PubMed ID: 8704891
[TBL] [Abstract][Full Text] [Related]
59. The seroepidemiology of Haemophilus influenzae type b prior to introduction of an immunization programme in Kathmandu, Nepal.
Marshall AS; Barker CI; Pulickal AS; Kibwana E; Gautam SC; Clutterbuck EA; Thorson SM; Shrestha S; Adhikari N; Pollard AJ; Kelly DF
PLoS One; 2014; 9(1):e85055. PubMed ID: 24465475
[TBL] [Abstract][Full Text] [Related]
60. [Haemophilus meningitis in properly vaccinated children: report of three cases].
Metreau Z; Le Bars H; Desgranges-Federico M; Monnier M; Ryckewaert A; Chasle V; Pierre M; Farges C; Guitteny MA
Arch Pediatr; 2013 May; 20(5):492-5. PubMed ID: 23566579
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
